These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36096123)

  • 21. The Clinical Features and Outcomes of Renal Amyloidosis in Tunisia.
    Ayed A; Salem MB; Letaief A; Salah MB; Handous I; Hamouda M; Aloui S; Skhiri H
    Saudi J Kidney Dis Transpl; 2022; 33(3):432-439. PubMed ID: 37843145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy.
    Aurich M; Bucur J; Vey JA; Greiner S; Aus dem Siepen F; Hegenbart U; Schönland S; Katus HA; Frey N; Mereles D
    Open Heart; 2023 Jul; 10(2):. PubMed ID: 37463823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
    Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
    Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light-chain amyloidosis with renal involvement: renal outcomes and validation of two renal staging systems in the Chinese population.
    Zhu Z; Yue C; Sun Y; Li X; Li M
    Amyloid; 2019 Dec; 26(4):186-191. PubMed ID: 31339366
    [No Abstract]   [Full Text] [Related]  

  • 25. A multicenter study of the clinical, laboratory characteristics, and potential prognostic factors in patients with amyloid A amyloidosis on hemodialysis.
    Bilgic Koylu E; Eren Sadioglu R; Eyupoglu S; Ergun I; Nergizoglu G; Keven K
    Hemodial Int; 2022 Apr; 26(2):207-215. PubMed ID: 34970831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.
    Kristen AV; Brokbals E; Aus dem Siepen F; Bauer R; Hein S; Aurich M; Riffel J; Behrens HM; Krüger S; Schirmacher P; Katus HA; Röcken C
    J Am Coll Cardiol; 2016 Jul; 68(1):13-24. PubMed ID: 27364045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.
    Rezk T; Salota R; Gan JJ; Lachmann HJ; Fontana M; Siew K; Martinez-Naharro A; Guillotte C; Bass P; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Dockrell M; Foard D; Lane T; Wechalekar AD; Hawkins PN; Walsh SB; Gillmore JD
    Br J Haematol; 2021 Sep; 194(6):1016-1023. PubMed ID: 34374069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors.
    Barge-Caballero G; Vázquez-García R; Barge-Caballero E; Couto-Mallón D; Paniagua-Martín MJ; Barriales-Villa R; Piñón-Esteban P; Bouzas-Mosquera A; Pombo-Otero J; Debén-Ariznavarreta G; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Med Clin (Barc); 2021 Apr; 156(8):369-378. PubMed ID: 32591181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre.
    Potysová Z; Merta M; Tesar V; Jancová E; Honsová E; Rysavá R
    Int Urol Nephrol; 2009 Dec; 41(4):941-5. PubMed ID: 19184513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and outcomes of renal amyloidosis in Hong Kong.
    Lin RCC; Yuen SK; Cheung SF; Tang HL; Fung SKS
    Nephrology (Carlton); 2022 Nov; 27(11):869-876. PubMed ID: 36054582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal Amyloidosis: A Clinicopathological Study From a Tertiary Care Hospital in Pakistan.
    Ahmed S; Nasir H; Moatasim A; Khalil F
    Cureus; 2022 Jan; 14(1):e21122. PubMed ID: 35165578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and clinical outcome of renal amyloidosis: a retrospective study.
    Abdallah E; Waked E
    Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):950-8. PubMed ID: 24029260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis.
    Celtik A; Sen S; Keklik F; Saydam G; Asci G; Sarsik B; Ozkahya M; Toz H
    Int Urol Nephrol; 2020 Jul; 52(7):1297-1304. PubMed ID: 32529382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of amyloid lymphadenopathy in uremic patients.
    Güz G; Ozdemir BH; Sezer S; Yakupoglu U; Demirhan B; Ozdemir FN; Haberal M
    Ren Fail; 2000; 22(5):613-21. PubMed ID: 11041293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing.
    Muchtar E; Gertz MA; Kyle RA; Lacy MQ; Dingli D; Leung N; Buadi FK; Hayman SR; Kapoor P; Hwa YL; Fonder A; Hobbs M; Gonsalves W; Kourelis TV; Warsame R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Rajkumar SV; Kumar SK; Dispenzieri A
    Mayo Clin Proc; 2019 Mar; 94(3):472-483. PubMed ID: 30770096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of 121 patients with renal amyloid a amyloidosis.
    Ahbap E; Kara E; Sahutoglu T; Basturk T; Koc Y; Sakaci T; Sevinc M; Akgol C; Ucar ZA; Kayalar AO; Bayraktar F; Ozagari AA; Unsal A
    J Res Med Sci; 2014 Jul; 19(7):644-9. PubMed ID: 25364365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers.
    Rezk T; Lachmann HJ; Fontana M; Naharro AM; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Hawkins PN; Gillmore JD
    Br J Haematol; 2019 Aug; 186(3):460-470. PubMed ID: 31124579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal amyloidosis: validation of a proposed histological scoring system in an independent cohort.
    Hoelbeek JJ; Kers J; Steenbergen EJ; Roelofs JJTH; Florquin S
    Clin Kidney J; 2021 Mar; 14(3):855-862. PubMed ID: 33777368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.